Identification of caspase-mediated decay of interferon regulatory factor (IRF)-3, exploited by a Kaposi's sarcoma-associated herpesvirus (KSHV) immunoregulatory protein.

Upon virus infection, the cell mounts an innate type I interferon (IFN) response to limit the spread. This response is orchestrated by the constitutively expressed IFN regulatory factor (IRF)-3 protein, which becomes post-translationally activated. Whilst the activation events are understood in detail, the negative regulation of this innate response is less well understood. Many viruses, including Kaposi's sarcoma-associated herpesvirus (KSHV), have evolved defence strategies against this IFN response. Thus, KSHV encodes a viral IRF (vIRF)-2 protein, sharing homology with cellular IRFs, and is a known inhibitor of the innate IFN response. Here, we show that vIRF-2 mediates IRF-3 inactivation by a mechanism involving caspase-3, although vIRF-2 itself is not pro-apoptotic. Importantly, we also show that caspase-3 participates in normal IRF-3 turnover in the absence of vIRF-2, during the antiviral response induced by poly(I:C) transfection. These data provide unprecedented insight into negative regulation of IRF-3 following activation of the type I IFN antiviral response, and the mechanism by which KSHV vIRF-2 inhibits this innate response.